The scientific focus adapted
to express the optimum potential
of your molecule

Unparalleled vision in metabolic disorders and risk assessment expertise for post-marketing studies and drug repositioning.

HeartArteryMacrophageLiverMusclePancreasAdipose Tissue

Preclinical development:
In-house predictive models and tracer technologies enable the generation of Proof of Concept efficacy data for your drugs.

Screening and lead validation utilize a dedicated research platform which combine with our focused scientific vision.


Physiogenex is a preclinical contract research organization (CRO) that offers outstanding consultancy and research services, specializing inmetabolic disorders such as diabetes, obesity,liver diseases (NASH), dyslipidemia,atherosclerosis and cardiovascular complications.

More than just a CRO, we are your R&D partner of choice to target your specific needs. Our models and technologies are customized and we deliver unparalleled scientific expertise for R&D, preclinical development, post-marketing studies and drug repositioning. We also offer in vivo preclinical imaging services.

We provide both the biopharmaceutical and nutraceutical companies with optimal and reliable solutions for successful strategic decision-making.

R&D, Preclinical and Post marketing studies

Insulin resistance

Hepatic steatosis
to fibrosis

Animal models
from basic to predictive
in-house models
Experimental platform
From gold-standard to innovative assays
Scientific expertise and translational vision